—
C+
C+ The full Closelook — membership. Open the C+ overview

Zimmer Biomet Holdings Inc (ZBH) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Zimmer Biomet Holdings Inc

ZBH in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Zimmer Biomet designs, manufactures and sells orthopaedic implants and instruments for hip and knee reconstruction, alongside sports-medicine, trauma and craniomaxillofacial products. It supplies surgeons, hospitals and distributors, and also offers the ROSA robotic system and ZBEdge data platform used during joint-replacement surgery. The company is headquartered in Warsaw, Indiana, and its shares trade in the United States under ZBH.
Where it sits in the stack
Zimmer Biomet holds no seat in Rubin, our index for the AI build-out; it sits instead in the diary's healthcare sleeve, which follows medical-device makers rather than compute or data-centre suppliers.
Who it is priced against
The diary's peer group for Zimmer Biomet is not yet populated; the name the market most often sets against it is Stryker.
Why Closelook tracks it
Zimmer Biomet is an S&P 500 constituent but carries no Rubin or other Closelook index seat, and the diary has not yet built a score for it; it appears in no quoted editions.
What the diary watches
The diary watches whether the shares recover toward their recent high or keep drifting below it, which would mark a shift in how the market is pricing its device business.

Zimmer Biomet Holdings Inc (ZBH) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for ZBH, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Medical Devices · United States · 8 names with week and year-to-date

Peer group

Medical Devices · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against ZBH on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 1.02%, quarterly · last 0.24 USD on 2026-06-25

Dividends and capital return

What ZBH pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.96 USD per share · a 1.02% yield on the 2026-09-17 close 4 distributions, paid quarterly 2026-09-17
  • Change on the year 0.0% against the prior twelve months prior twelve months 0.96 USD per share
  • Last distribution 0.24 USD per share as the price series records it, within days of the ex-date 2026-06-25
  • By calendar year 2023: 0.48 USD (partial) · 2024: 0.96 USD · 2025: 0.96 USD · 2026: 0.48 USD to date first distribution recorded in the three-year window: 2023-09-28

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Zimmer Biomet Holdings Inc (ZBH)?

Zimmer Biomet Holdings Inc trades as ZBH on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is ZBH in a Closelook index?

Not currently — Zimmer Biomet Holdings Inc is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does ZBH trade against its moving averages?

Pullback inside an uptrend stack: Trades -1.8% vs the 50-day and +3.2% vs the 200-day average, 11.3% below the 52-week high and +19.1% off the 52-week low; a golden cross printed 26 sessions ago. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Zimmer Biomet Holdings Inc do?

Zimmer Biomet designs, manufactures and sells orthopaedic implants and instruments for hip and knee reconstruction, alongside sports-medicine, trauma and craniomaxillofacial products. It supplies surgeons, hospitals and distributors, and also offers the ROSA robotic system and ZBEdge data platform used during joint-replacement surgery. The company is headquartered in Warsaw, Indiana, and its shares trade in the United States under ZBH. The diary's peer group for Zimmer Biomet is not yet populated; the name the market most often sets against it is Stryker.

Where does Zimmer Biomet Holdings Inc sit in the AI build-out?

Zimmer Biomet holds no seat in Rubin, our index for the AI build-out; it sits instead in the diary's healthcare sleeve, which follows medical-device makers rather than compute or data-centre suppliers. Zimmer Biomet is an S&P 500 constituent but carries no Rubin or other Closelook index seat, and the diary has not yet built a score for it; it appears in no quoted editions.

Does Zimmer Biomet Holdings Inc pay a dividend?

Zimmer Biomet Holdings Inc has paid 0.96 USD per share over the last twelve months, paid quarterly, a trailing yield of 1.02% on the 2026-09-17 close; the last distribution recorded in the price series was 0.24 USD on 2026-06-25. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for ZBH, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Medical Devices. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.